title: Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
authors.affiliation: Biological Therapies Group, Royal Marsden Hospital, London, UK.
authors.forename: M E
authors.initials: ME
authors.lastname: Gore
authors.forename: P
authors.initials: P
authors.lastname: Riches
authors.forename: K
authors.initials: K
authors.lastname: MacLennan
authors.forename: M
authors.initials: M
authors.lastname: O'Brien
authors.forename: J
authors.initials: J
authors.lastname: Moore
authors.forename: G
authors.initials: G
authors.lastname: Dadian
authors.forename: A
authors.initials: A
authors.lastname: Lorentzos
authors.forename: R
authors.initials: R
authors.lastname: Garth
authors.forename: E
authors.initials: E
authors.lastname: Moskovic
authors.forename: D
authors.initials: D
authors.lastname: Archer
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity*
chemical_list: D007376:Interleukin-2